Atossa Therapeutics
ATOS
#9336
Rank
โ‚น8.29 B
Marketcap
โ‚น64.21
Share price
-1.90%
Change (1 day)
-24.41%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -โ‚น2.62 Billion

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚น2.29 Billion, an increase over its 2023 earnings that were of -โ‚น2.7 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น2.62 Billion14.44%
2024 -โ‚น2.29 Billion-15.25%
2023 -โ‚น2.7 Billion11.62%
2022 -โ‚น2.42 Billion30.84%
2021 -โ‚น1.85 Billion15.58%
2020 -โ‚น1.6 Billion3.41%
2019 -โ‚น1.55 Billion51.16%
2018 -โ‚น1.03 Billion40.41%
2017 -โ‚น0.73 Billion27.54%
2016 -โ‚น0.58 Billion-47.49%
2015 -โ‚น1.09 Billion-17.25%
2014 -โ‚น1.32 Billion35.91%
2013 -โ‚น0.97 Billion112.3%
2012 -โ‚น0.46 Billion46.53%
2011 -โ‚น0.32 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.900 T-107,442.61%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น119.35 B-4,517.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น115.21 B-4,364.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-โ‚น0.71 Billion-74.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
โ‚น3.73 B-238.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น9.78 Billion 261.87%๐Ÿ‡บ๐Ÿ‡ธ USA